Rispolept Consta 37.5 mg powder and solvent for prolonged-release suspension for injection
Country: Bulgarija
Lingwa: Bulgaru
Sors: Изпълнителна агенция по лекарствата
Fuljett ta 'informazzjoni
(PIL)
03-01-2018
Karatteristiċi tal-prodott
(SPC)
20-12-2017
Ingredjent attiv:
Рисперидон
Disponibbli minn:
Johnson & Johnson D.O.O.
Kodiċi ATC:
N05AX8
INN (Isem Internazzjonali):
Risperidone
Dożaġġ:
37.5 mg powder and solvent for prolonged-release suspension for injection
Sommarju tal-prodott:
Rispolept Consta, 37.5 mg powder and solvent for prolonged-release suspension for injection
Data ta 'l-awtorizzazzjoni:
2015-10-07
